Cargando...
Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
BACKGROUND: It is well known that human clear cell renal cell carcinoma (ccRCC) is a highly immunogenic and chemo-resistant tumor. Recently, emerging data suggest that the immune checkpoint blockade therapy is an important breakthrough in the treatment against ccRCC. HHLA2, a recently reported membe...
Guardado en:
| Publicado en: | Cancer Cell Int |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6469208/ https://ncbi.nlm.nih.gov/pubmed/31015801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0813-2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|